<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/xsl" href="static/style.xsl"?><OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2026-05-28T23:24:43Z</responseDate><request verb="GetRecord" identifier="oai:riuma.uma.es:10630/17156" metadataPrefix="rdf">https://riuma.uma.es/rest/oai/request</request><GetRecord><record><header><identifier>oai:riuma.uma.es:10630/17156</identifier><datestamp>2026-02-03T12:30:30Z</datestamp><setSpec>com_10630_2254</setSpec><setSpec>col_10630_37959</setSpec></header><metadata><rdf:RDF xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:doc="http://www.lyncode.com/xoai" xmlns:ds="http://dspace.org/ds/elements/1.1/" xmlns:ow="http://www.ontoweb.org/ontology/1#" xmlns:rdf="http://www.openarchives.org/OAI/2.0/rdf/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/rdf/ http://www.openarchives.org/OAI/2.0/rdf.xsd">
   <ow:Publication rdf:about="oai:riuma.uma.es:10630/17156">
      <dc:title>Selection of resistance to cisplatin in saccharomyces cerevisiae as a model for antineoplastic drugs studies</dc:title>
      <dc:creator>Burgos-Molina, Antonio Manuel</dc:creator>
      <dc:creator>Lumbreras-Vega, Luis Joaquín</dc:creator>
      <dc:creator>Gil-Carmona, Luisa</dc:creator>
      <dc:creator>Ruiz-Gómez, Miguel José</dc:creator>
      <dc:subject>Medicina</dc:subject>
      <dc:description>The budding yeast (S. cerevisiae) is an excellent eukaryotic model to study the antineoplastic drugs effects, due to the well-characterized metabolic and genetic characteristics and the conserved similarity in molecular mechanisms with other species including human cells.&#xd;
The aim of this work is to study the effect of cisplatin on S. cerevisiae cells and select cisplatin-resistant cells of this organism as a model of study of resistance to antineoplastic drugs.</dc:description>
      <dc:date>2019-01-16T11:56:55Z</dc:date>
      <dc:date>2019-01-16T11:56:55Z</dc:date>
      <dc:date>2018-11</dc:date>
      <dc:date>2019-01-16</dc:date>
      <dc:type>conference output</dc:type>
      <dc:identifier>https://hdl.handle.net/10630/17156</dc:identifier>
      <dc:language>spa</dc:language>
      <dc:relation>16th ASEICA International Congress 2018</dc:relation>
      <dc:relation>Valencia (España)</dc:relation>
      <dc:relation>06-08/11/2018</dc:relation>
      <dc:rights>http://creativecommons.org/licenses/by-nc-nd/4.0/</dc:rights>
      <dc:rights>open access</dc:rights>
      <dc:rights>Attribution-NonCommercial-NoDerivatives 4.0 Internacional</dc:rights>
   </ow:Publication>
</rdf:RDF>
</metadata></record></GetRecord></OAI-PMH>